T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases

NCT06048718 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Metastatic Breast Cancer

Interventions

DRUG: Trastuzumab-Deruxtecan (T-DXd)

Sponsor

MedSIR

Collaborators

[object Object]